Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade to BB- from B+
From Bombardier Inc.
Via GlobeNewswire
Tickers BDRBF TSX:BBD-A TSX:BBD-B
XOMA Royalty Declares Quarterly Preferred Stock Dividends
From XOMA Royalty Corporation
Via GlobeNewswire
Tickers XOMA XOMAO XOMAP
Near Surface Infill-Drilling to Assess Open Pit Production Intersects 45.38 g/t Au over 3.13 m core length, including 141.00 g/t Au over 0.88 m
From Red Pine Exploration Inc.
Via GlobeNewswire
Tickers RDEXF TSX-V:RPX
Palvella Therapeutics Granted Sixth U.S. Patent Covering 0.1–20% Anhydrous Compositions of Rapamycin and Other mTOR Inhibitors
From Palvella Therapeutics Inc.
Via GlobeNewswire
Tickers PVLA
Zefiro Subsidiary Awarded USD $19.6 Million Plugging & Abandonment Management Contract from the Ohio Department of Natural Resources
From Zefiro Methane Corp
Via GlobeNewswire
Tickers ZEFIF
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers OGN
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers IOVA
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Open Lending
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers LPRO
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avis Budget Group
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers CAR
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers ELV
Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System
From Gradient Denervation Technologies
Via GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Red Cat Holdings
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers RCAT
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
From Faruqi & Faruqi LLP
Via GlobeNewswire
Tickers WST
SunRocket Capital Provides Financing for Golden Gate Capital's C&I Rooftop Solar Installation in New Jersey
From SunRocket Capital
Via GlobeNewswire
Troilus Agrees to Commercial Offtake Terms with Aurubis for Its Copper-Gold Concentrate
From Troilus Gold Corp.
Via GlobeNewswire
Tickers CHXMF TSX:TLG
Extensive Greenland Lithium Exploration Campaign Launched by Brunswick Exploration
From Brunswick Exploration
Via GlobeNewswire
Tickers BRWXF TSX-V:BRW
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
Climb Channel Solutions Announces North American Alliance with Bugcrowd
From Climb Channel Solutions
Via GlobeNewswire
Tickers CLMB
Miguel Ángel Jiménez Signs with Newton Golf Company Following Tour Win Using Newton Fast Motion Shaft
From Newton Golf Company
Via GlobeNewswire
Tickers NWTG
Adant and QuantalRF Partner to Advance Antenna Performance in Wi-Fi Access Points
From QuantalRF AG
Via GlobeNewswire
BPGbio Announces Presentation of Preliminary Clinical Data of Investigational BPM31510 for Primary CoQ10 Deficiency
From BPGbio
Via GlobeNewswire
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates
From Biomea Fusion, Inc.
Via GlobeNewswire
Tickers BMEA
Axsome Therapeutics to Present Data Spanning the SYMBRAVO® (meloxicam and rizatriptan) Clinical Program at the 67th Annual Scientific Meeting of the American Headache Society (AHS)
From Axsome Therapeutics, Inc.
Via GlobeNewswire
Tickers AXSM
Gogo successfully completes first 5G end-to-end call.
From Gogo Business Aviation Ltd
Via GlobeNewswire
Tickers GOGO
Diagonal’s First-in-Class Clustering Antibody, DIAG723, Receives Orphan Drug Designation (ODD) from U.S. FDA and an ODD Positive Opinion from EMA for Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
From DIAGONAL THERAPEUTICS, INC
Via GlobeNewswire
OTC Markets Group Welcomes Digital Brands Group, Inc. to OTCQX
From OTC Markets
Via GlobeNewswire
Tickers DBGI OTCM
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
From Avalo Therapeutics
Via GlobeNewswire
Tickers AVTX
HydroGraph Announces Kjirstin Breure as Board Chair
From Hydrograph Clean Power Inc.
Via GlobeNewswire
Tickers CSE:HG HGRAF
Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer
From Climb Bio, Inc.
Via GlobeNewswire
Tickers CLYM
Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.